| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.46B | +35.6% |
| Cost of Revenue | $429.9M | +50.7% |
| Gross Profit | $1.03B | +30.1% |
| R&D Expense | $427.2M | +31.8% |
| SG&A Expense | $758.5M | -13.5% |
| Operating Income | -$1.05B | +0.5% |
| Pre-tax Income | -$1.04B | +0.6% |
| Income Tax | $20.9M | +74.7% |
| Net Income | -$1.06B | -0.2% |
| EPS (Basic) | -$1.82 | +11.2% |
| EPS (Diluted) | -$1.82 | +11.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $719.9M | -29.0% |
| Accounts Receivable | $537.0M | +16.3% |
| Current Assets | $1.41B | -12.4% |
| Total Assets | $3.40B | -5.2% |
| Current Liabilities | $1.17B | +14.7% |
| Total Liabilities | $1.49B | +6.9% |
| Stockholders' Equity | $1.90B | -12.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.9M | +539.2% |
| Capital Expenditures | $51.2M | -50.7% |
| Investing Cash Flow | -$51.2M | +79.2% |
| Financing Cash Flow | -$258.9M | -124.6% |
| Free Cash Flow | -$33.3M | +67.0% |